Market Overview

Goldman Sachs: Time To Buy Carlisle Companies And Grifols

Related CSL
Earnings Scheduled For February 7, 2019
Benzinga's Top Upgrades, Downgrades For December 17, 2018

In a report published Monday, Goldman Sachs analysts reviewed the Global Medical Technology: Medical Supplies market, expressing confidence in the ability of the global plasma market to grow its volumes at 6-8 percent in the medium term.

The analysts believe the increased penetration of and additional uptake in developing countries is likely to drive this growth. The industry is expected to witness robust growth for another two to three years before pricing is impacted.

The analysts maintained their Buy rating on Carlisle Companies, Inc. (NYSE: CSL) and Grifols SA, Barcelona (NASDAQ: GRFS), given both companies' "strong relative growth outlooks."

These companies make up two of the three largest players in the U.S./EU markets, which currently have significant barriers to entry, apart from "long lead times for building incremental capacity, and barriers to obtaining the raw material – as maintaining supply/demand balance in the medium term," the analysts said.

Although there might be short-term pricing headwinds, including a modest weakening in U.S. IG prices, these are more likely to affect smaller players, while Carlisle Companies and Grifols are expected to be able to better absorb pricing declines.

The analysts believe that Carlisle Companies and Grifols offer the best ways to gain exposure to the plasma market.

Latest Ratings for CSL

Dec 2018OppenheimerUpgradesPerformOutperform
Nov 2018Longbow ResearchUpgradesNeutralBuy
Oct 2018BMO CapitalMaintainsMarket PerformMarket Perform

View More Analyst Ratings for CSL
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Reiteration Analyst Ratings


Related Articles (CSL + GRFS)

View Comments and Join the Discussion!

Latest Ratings

CBBMorgan StanleyUpgrades10.0
GDCredit SuisseDowngrades184.0
GEOJP MorganDowngrades26.0
TRUERBC CapitalDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

China Unicom Launches World's First 399RMB 5" 4G LTE XiaoLaJiao Smartphone Powered by Marvell's ARMADA Mobile SoC

Benzinga's Top #PreMarket Gainers